Skip to content

Cellistic

Active Public limited companyfounded 2020active for 6 yearsRue Edouard Belin 2, 1435 Mont-Saint-GuibertKBO/BCE: BE 0740.785.238 subsidiary of Ncardia Holding SA#1 company by staff growth in Belgium, Pharmaceuticals sector

Board

1 director, 1 auditor, no change since June 2026

Deed of 12-06-2026Reappointment: PwC Reviseurs d'Entreprises SRL (statutory auditor)Permanent representative: Romain Seffer · General meeting of 30-09-2025

Sole director
since 05-03-2026 6-year term from 2026
listed in the 2025 annual accounts, filed on 16-06-2026
Statutory auditor, permanent representative Romain Seffer
since 09-09-2022 3-year term from 2026
listed in the 2025 annual accounts, filed on 16-06-2026

Office holders in the KBO →

Mandates through the years

5 names, the dashed line is today
Jason Conner
Sole director
Gustavo Mahler
Sole director
Stefan BRAAM
Sole director
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
  • Jason Conner
    • Sole director, since before 31-12-2025
  • PwC Réviseurs d'Entreprises SRL
    • Statutory auditor, from 09-09-2022 to date
  • Gustavo Mahler
    • Sole director, appointed by deed of 26-08-2024, until 07-05-2026
  • Stefan BRAAM
    • Sole director, from 30-12-2019 to 26-08-2024
  • BDO Réviseurs d’Entreprises SCRL
    • Statutory auditor, from 31-12-2019 to 05-10-2022

Control

Consolidating parent
consolidates
This company
Cellistic
Equity -€44.3m
Loss €13.5m in 2025

and 1 other shareholder

Capital

Capital
€6,331,124.91
Shares
6,331,125
Contribution per share
€1.00
Equity per share
-€7.00 in 2025
Source
deed of 06-03-2023

Owners through the years

as the annual accounts name them
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 08-01-2020 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 11:00
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Toutes opérations prévues par la loi sauf décision contraire de l’assemblée générale à majorité des voix”

Shareholders

2 owners

Owners 2

Capital transactions

Shareholders according to the deeds
After the capital increase deed of 06-03-2023 ↗
  • Ncardia Holding (BE 0565.979.162) €5,661,791.91 · “créance à l’encontre de la société”
Capital over time
  1. 06-03-2023 Capital increase of €5,661,791.91 · to €6,331,124.91 · 5,661,792 new shares, 89.4% of the 6,331,125 shares after the increase · in kind

Next steps